Gentiva Health Services
The 10-second takeaway
For the quarter ended June 30 (Q2), Gentiva Health Services missed slightly on revenue and beat expectations on earnings per share.
Compared to the prior-year quarter, revenue dropped and GAAP earnings per share improved significantly.
Gross margins improved, operating margins contracted, and net margins expanded.
Gentiva Health Services logged revenue of $427.7 million. The six analysts polled by S&P Capital IQ anticipated revenue of $436.2 million on the same basis. GAAP reported sales were 4.7% lower than the prior-year quarter's $448.7 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.35. The six earnings estimates compiled by S&P Capital IQ predicted $0.28 per share. GAAP EPS of $0.46 for Q2 were 171% higher than the prior-year quarter's $0.17 per share. (The prior-year quarter included $0.02 per share in earnings from discontinued operations.)
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 47.9%, 10 basis points better than the prior-year quarter. Operating margin was 9.6%, 20 basis points worse than the prior-year quarter. Net margin was 3.3%, 210 basis points better than the prior-year quarter.
Next quarter's average estimate for revenue is $428.4 million. On the bottom line, the average EPS estimate is $0.28.
Next year's average estimate for revenue is $1.73 billion. The average EPS estimate is $1.23.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 293 members out of 310 rating the stock outperform, and 17 members rating it underperform. Among 92 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 87 give Gentiva Health Services a green thumbs-up, and five give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Gentiva Health Services is hold, with an average price target of $7.90.
- Add Gentiva Health Services to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no positions in the stocks mentioned above. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.